For the Inventor, By the Inventor

Enter assignee name

Lexington, MA, United States of America

Shire-nps Pharmaceuticals, Inc.

USPTO Granted Patents = 19

Trademarks = 8

Forward Citations = 1

Loading Chart...

Loading Chart...

12 inventors (with patents filed for the assignee):

Thomas B Marriott (18 out of 25 patents)

Jennifer Lopansri (18 out of 24 patents)

Consuelo M Blosch (18 out of 24 patents)

4. Elizabeth Lemaire Sanguinetti (18 out of 24 patents)

5. Kevin Holmes (1 out of 6 patents)

6. Angela Norton (1 out of 12 patents)

7. Clark Qun Pan (1 out of 52 patents)

8. Rongxin Shi (1 out of 2 patents)

9. Bryan James Goodwin (1 out of 1 patent)

10. David Bruce Lloyd (1 out of 1 patent)

11. Chuan Shen (1 out of 2 patents)

12. Sujit Jain (1 out of 2 patents)

19 patents: Sort by Forward Citations

1. 11634468 - Parathyroid hormone variants (2023-04-25),

2. 9999656 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-06-19),

3. 9993528 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-06-12),

4. 9987335 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-06-05),

5. 9987334 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-06-05),

6. 9981016 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-05-29),

7. 9981015 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-05-29),

8. 9981014 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-05-29),

9. 9974838 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-05-22),

10. 9974837 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-05-22),

11. 9974836 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-05-22),

12. 9974835 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-05-22),

13. 9968658 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-05-15),

14. 9968657 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-05-15),

15. 9968656 - Treatment of short bowel syndrome patients with colon-in-continuity (2018-05-15),

Shire-NPS Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on discovering, developing, and commercializing medicines. They specialize in rare diseases and conditions, with a mission to improve the lives of patients worldwide. With a dedication to innovation and groundbreaking research, Shire-NPS Pharmaceuticals aims to provide effective and transformative treatments for unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

19 Patents

#41 in Lexington, MA

#1,008 in Massachusetts

#16,626 in US

#31,712 in the World

Lexington, MA, United States of America

Shire-nps Pharmaceuticals, Inc.

Forward Citations = 1

12 inventors:

Thomas B Marriott (18 out of 25 patents)

Jennifer Lopansri (18 out of 24 patents)

Consuelo M Blosch (18 out of 24 patents)

4. Elizabeth Lemaire Sanguinetti (18 out of 24 patents)

5. Kevin Holmes (1 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…